Molecular switch for CLC-K Cl − channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands
- 29 January 2008
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (4) , 1369-1373
Abstract
ClC-Ka and ClC-Kb Cl − channels are pivotal for renal salt reabsorption and water balance. There is growing interest in identifying ligands that allow pharmacological interventions aimed to modulate their activity. Starting from available ligands, we followed a rational chemical strategy, accompanied by computational modeling and electrophysiological techniques, to identify the molecular requisites for binding to a blocking or to an activating binding site on ClC-Ka. The major molecular determinant that distinguishes activators from blockers is the level of planarity of the aromatic portions of the molecules: only molecules with perfectly coplanar aromatic groups display potentiating activity. Combining several molecular features of various CLC-K ligands, we discovered that phenyl-benzofuran carboxylic acid derivatives yield the most potent ClC-Ka inhibitors so far described (affinity p -chlorophenoxy-propionic acid (3-phenyl-CPP) stems primarily from the conformational constraint provided by the phenyl-benzofuran ring. Several other key structural elements for high blocking potency were identified through a detailed structure–activity relationship study. Surprisingly, some benzofuran-based drugs inhibit ClC-Kb with a similar affinity of <10 μM, thus representing the first inhibitors for this CLC-K isoform identified so far. Based on our data, we established a pharmacophore model that will be useful for the development of drugs targeting CLC-K channels.Keywords
This publication has 26 references indexed in Scilit:
- The Structure of the Cytoplasmic Domain of the Chloride Channel ClC-Ka Reveals a Conserved Interaction InterfaceStructure, 2007
- Molecular physiology of renal ClC chloride channels/transportersCurrent Opinion in Nephrology and Hypertension, 2006
- Barttin modulates trafficking and function of ClC-K channelsProceedings of the National Academy of Sciences, 2006
- Activation and Inhibition of Kidney CLC-K Chloride Channels by FenamatesMolecular Pharmacology, 2006
- FUNCTION OF CHLORIDE CHANNELS IN THE KIDNEYAnnual Review of Physiology, 2005
- Association Analysis Between Hypertension and CYBA, CLCNKB, and KCNMB1 Functional Polymorphisms in the Japanese Population-The Suita Study-Circulation Journal, 2005
- Activating Mutation of the Renal Epithelial Chloride Channel ClC-Kb Predisposing to HypertensionHypertension, 2004
- Investigations of Pharmacologic Properties of the Renal CLC-K1 Chloride Channel Co-expressed with Barttin by the Use of 2-(p-Chlorophenoxy)Propionic Acid Derivatives and Other Structurally Unrelated Chloride Channels BlockersJournal of the American Society of Nephrology, 2004
- Molecular Requisites for Drug Binding to Muscle CLC-1 and Renal CLC-K Channel Revealed by the Use of Phenoxy-Alkyl Derivatives of 2-(p-Chlorophenoxy)Propionic AcidMolecular Pharmacology, 2002
- A chloride channel widely expressed in epithelial and non-epithelial cellsNature, 1992